Male circumcision for prevention of oncogenic HPV infection

The Lancet

Volumn 378, Issue 9788, 2011, Pages 314-315

  Tobian, Aaron Ar ^a   Quinn, Thomas C ^a,b   Gray, Ronald H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CIRCUMCISION; CONDOM; DISEASE TRANSMISSION; FEMALE; GENOTYPE; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; MALE; OBSERVATIONAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION;

EID: 79960702294     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61162-8     Document Type: Letter

References (6)

1. J Monsonego Genital infection with HPV in men: research into practice Lancet 377 2011 881 883
2. AR Giuliano, JH Lee, W Fulp et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study Lancet 377 2011 932 940
3. AA Tobian, RH Gray, TC Quinn Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision Arch Pediatr Adolesc Med 164 2010 78 84
4. MJ Wawer, AA Tobian, G Kigozi et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda Lancet 277 2011 209 218
5. AR Giuliano, E Lazcano, LL Villa et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study Int J Cancer 124 2009 1251 1257
6. AR Giuliano, JM Palefsky, S Goldstone et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males N Engl J Med 364 2011 401 411